Browsing by Author Grant, Peter Thomas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2011Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancerRussell, Peter; Friedlander, Michael; Grant, Peter Thomas; Hopper, John Llewelyn; Jenkins, M. A.; kConFab Investigators, .; Kiely, Belinda E; McLachlan, Sue Anne; Milne, R; Phillips, Kelly-Anne; Stanhope, L; Weideman, Prue C; Central Clinical School: PathologyAdequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer, Familial Cancer, vol.10, 3, 2011,pp 505-514
2015Circulating 25-hydroxyvitamin D and survival in women with ovarian cancerBrand, Alison; deFazio, Anna; Blomfield, Penelope; Grant, Peter Thomas; Ibiebele, T; Nagle, Christina M.; Neale, Rachel E; Perrin, Lewis; Protani, Melinda; Webb, Penelope M.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteCirculating 25-hydroxyvitamin D and survival in women with ovarian cancer, The American Journal of Clinical Nutrition, vol.102, 1, 2015,pp 109-114
2013Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyBrand, Alison; Donohue, Mark; Gainford, Corona; Gebski, Val; Martyn, Julie; Stockler, Martin; Blinman, Prunella L; Bloomfield, Penny; Friedlander, Michael L.; Grant, Peter Thomas; Kichenadasse, G; Shannon, Catherine; Vaughan, Michelle; Western Clinical School: Medicine (Westmead); Linguistics; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFeasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study, Journal of Gynecologic Oncology, vol.24, 4, 2013,pp 359-366
2017Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancerKiely, Belinda Emma; Russell, Peter; Bressel, Mathias; Camm, S.; et al, Various; Grant, Peter Thomas; Hickey, Martha; Lee, Y. C.; McLachlan, Sue Anne; Milne, R; Picken, S; Smith, C.; NH&MRC Clinical Trials Centre; Central Clinical School: PathologyImproved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer, Familial Cancer, vol.16, 4, 2017,pp 461-469